|
|
 |
|
|
|
|
1. G. Evans, Ed. Animal Clinical Chemistry: A primer for Toxicologists. Taylor & Francis Press, London, 1996. |
|
|
|
|
|
|
|
|
2. G. Odel, K. Schloemer, M. Harvey, and R. Malcolm. Cost-effectiveness of laboratories. Applied Clinical Trials 4: 32, 1995. |
|
|
|
|
|
|
|
|
3. A. Hill. The pros and cons of using a central laboratory versus a local laboratory. Personal Communication presented at central laboratories, Blood brothers or spin doctors? organised by ACRPI on December 1995 at the Royal College of Pathologists, London. |
|
|
|
|
|
|
|
|
4. J. C. Bloom. Issues in the selection and use of centralised laboratories. Applied Clinical Trials. April Supplement 1, 1995. |
|
|
|
|
|
|
|
|
5. C. J. Fenning. Optimizing the use of a central laboratory in Europe. Applied Clinical Trials 3: 28, 1994. |
|
|
|
|
|
|
|
|
6. S. T. Barnett and J. A. James. Measuring the clinical development process. Applied Clinical Trials 4: 44, 1995. |
|
|
|
|
|
|
|
|
7. K. A. Getz and J. R. Vogel. Achieving results with CROs: Their evolving role in clinical development. Applied Clinical Trials 4: 32, 1995. |
|
|
|
|
|